GlassScriptPhysician profile
William R Palmer
NPI 1457374910
$24,261.02
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $3,820 · 2021: $1,510.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13,416.88 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $5,985.25 | 2019-2020 | |
| Pfizer INC. | $889.77 | 2019-2021 | |
| Celgene Corporation | $511.36 | 2019 | |
| Abbvie INC. | $435.95 | 2019-2021 | |
| Ucb, INC. | $387.26 | 2019-2021 | |
| Genentech USA, INC. | $310.30 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $286.03 | 2020-2021 | |
| Pacira Therapeutics, INC. | $271.54 | 2019-2021 | |
| Lilly USA, LLC | $266.22 | 2019-2021 | |
| Glaxosmithkline, LLC. | $229.29 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $224.84 | 2019-2020 | |
| Janssen Biotech, INC. | $224.61 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $178.90 | 2019 | |
| Mallinckrodt Enterprises LLC | $156.35 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $93.84 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $81.13 | 2019-2020 | |
| Antares Pharma, INC. | $43.36 | 2019 | |
| Merck Sharp & Dohme LLC | $40.88 | 2019-2020 | |
| Radius Health, INC. | $40.61 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $29.86 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $28.99 | 2021 | |
| Horizon Therapeutics Plc | $25.72 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.21 | 2019 | |
| Boston Scientific Corporation | $19.49 | 2019 | |
| United Therapeutics Corporation | $15.69 | 2020 | |
| Eisai INC. | $11.72 | 2020 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.